Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma
- PMID: 8986952
- DOI: 10.1002/(sici)1096-9071(199701)51:1<67::aid-jmv11>3.0.co;2-1
Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma
Abstract
A series of 54 synthetic peptides, 15-20 residues long, that represented selected parts of the structural proteins of hepatitis C virus (HCV) were tested for immunoreactivity with a panel of 45 plasma samples from potential blood donors who were known to be seropositive for anti-HCV. Most of the ten peptides that represented the core protein showed reactivity with most of the panel samples. All except one of the 20 peptides that represented non-hypervariable regions of envelope proteins E1 and E2 showed little or no reactivity. In contrast, 18 of the the 24 peptides that represented variants of the hypervariable region 1 of the E2 protein reacted with at least one panel sample. Notably, 40% of the panel samples cross-reacted with two or more different peptides sequences some of which differed by more than 50%. Two panel samples each cross-reacted with seven different peptide sequences. The results suggest a broad anti-hypervariable region antibody specificity in many anti-HCV-seropositive samples and possible limits on the mutability of hypervariable region sequences. The work contributes to understanding the immunogenicity and persistence of HCV.
Similar articles
-
Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.Viral Immunol. 1996;9(2):89-96. doi: 10.1089/vim.1996.9.89. Viral Immunol. 1996. PMID: 8822625
-
Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.J Virol. 1999 Feb;73(2):1118-26. doi: 10.1128/JVI.73.2.1118-1126.1999. J Virol. 1999. PMID: 9882313 Free PMC article.
-
Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.Virology. 1998 Nov 10;251(1):158-64. doi: 10.1006/viro.1998.9393. Virology. 1998. PMID: 9813211
-
Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain?Antiviral Res. 2001 Nov;52(2):153-9. doi: 10.1016/s0166-3542(01)00180-2. Antiviral Res. 2001. PMID: 11672825 Review.
-
From hepatitis C virus immunoproteomics to rheumatology via cross-reactivity in one table.Curr Opin Rheumatol. 2019 Sep;31(5):488-492. doi: 10.1097/BOR.0000000000000606. Curr Opin Rheumatol. 2019. PMID: 31356379 Review.
Cited by
-
HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development.Int J Mol Sci. 2020 Sep 16;21(18):6781. doi: 10.3390/ijms21186781. Int J Mol Sci. 2020. PMID: 32947858 Free PMC article. Review.
-
Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters.J Virol. 2000 Mar;74(6):2541-9. doi: 10.1128/jvi.74.6.2541-2549.2000. J Virol. 2000. PMID: 10684268 Free PMC article.
-
Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry.Front Immunol. 2018 Sep 27;9:2146. doi: 10.3389/fimmu.2018.02146. eCollection 2018. Front Immunol. 2018. PMID: 30319614 Free PMC article. Review.
-
Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses.J Biosci. 2003 Apr;28(3):305-10. doi: 10.1007/BF02970149. J Biosci. 2003. PMID: 12734408 Review.
-
Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouse.Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):e81-8. doi: 10.1016/j.cimid.2010.02.006. Epub 2010 Mar 17. Comp Immunol Microbiol Infect Dis. 2010. PMID: 20299097 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases